EUVIMEDEUVIMED entdecken
Crossref

Post-COVID syndrome: A multisystemic perspective on long-term complications

Malliga Rajendran, Akshaya Satheeshkumar, Praveen Kumar Chandra Sekar, Ramakrishnan Veerabathiran

Tanzania Journal of Health Research · 20.10.2025 · 26 (6) · 2811-2831

DOI: 10.4314/thrb.v26i6.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tanzania Journal of Health Research, online erschienen am 20.10.2025. Verfasst von Malliga Rajendran und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Long COVID-19, characterized by persistent symptoms post-SARS-CoV-2 infection, presents a complex challenge due to poorly understood underlying mechanisms. This review aims to comprehensively examine risk factors, genetic predispositions, current treatments, and future research directions.

Methods

A systematic review of literature from PubMed, Google Scholar, and Embase was conducted. Studies focusing on epidemiological risks, genetic variations (ACE2, TMPRSS2), immune dysregulation, and Long COVID-19 treatments were analyzed. The efficacy of current therapies, including symptom management and immunomodulation, was evaluated to highlight research gaps.

Results

Comorbidities like diabetes, obesity, hypertension, and cardiovascular disease significantly increase Long COVID-19 risk. Genetic susceptibility, particularly ACE2 and TMPRSS2 variations, influences disease severity. Immune dysregulation, including persistent inflammation and altered T-cell responses, contributes to prolonged symptoms. Current treatments focus on symptom relief, rehabilitation, and immunomodulatory therapies like anakinra and melatonin, but lack standardization. Future research should prioritize identifying Long COVID-19 phenotypes and utilizing multi-omics for personalized treatments.

Conclusion

Long COVID-19 poses a substantial healthcare burden. Future studies should focus on identifying distinct patient clusters for targeted interventions. Multi-omics approaches are promising for biomarker discovery and personalized therapy. Large-scale clinical trials are needed to evaluate anti-inflammatory, antiviral, and neuroprotective drugs. An integrated, multidisciplinary approach is essential for addressing long-term consequences and developing evidence-based treatments.

Zitieren

APA

Rajendran, M., Satheeshkumar, A., Sekar, P. K. C., & Veerabathiran, R. (2025). Post-COVID syndrome: A multisystemic perspective on long-term complications. Tanzania Journal of Health Research, 26(6), 2811-2831. https://doi.org/10.4314/thrb.v26i6.7

Vancouver

Rajendran M, Satheeshkumar A, Sekar PKC, Veerabathiran R. Post-COVID syndrome: A multisystemic perspective on long-term complications. Tanzania Journal of Health Research. 2025;26(6):2811-2831. doi:10.4314/thrb.v26i6.7

BibTeX
@article{Rajendran2025,
  author = {Rajendran, Malliga and Satheeshkumar, Akshaya and Sekar, Praveen Kumar Chandra and Veerabathiran, Ramakrishnan},
  title = {Post-COVID syndrome: A multisystemic perspective on long-term complications},
  journal = {Tanzania Journal of Health Research},
  year = {2025},
  volume = {26},
  number = {6},
  pages = {2811--2831},
  doi = {10.4314/thrb.v26i6.7}
}
Kostenlos starten →